Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.5 USD | +1.92% | -7.34% | -27.56% |
13/05 | Transcript : Cytokinetics, Incorporated - Special Call | |
09/05 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.56% | 622.41Cr | |
+7.51% | 11TCr | |
+11.38% | 11TCr | |
-12.61% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.49% | 1.68TCr | |
+37.48% | 1.25TCr | |
-23.95% | 808.97Cr |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- HC Wainwright Adjusts Cytokinetics Price Target to $58 From $49, Maintains Buy Rating